Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.

Kowala, Mark C; Murugesan, Natesan; Tellew, John; Carlson, Kenneth; Monshizadegan, Hossain; Ryan, Carol; Gu, Zhengxiang; Kane, Bridgette; Fadnis, Leena; Baska, Rose Ann; Beyer, Sophie; Arthur, Susan; Dickinson, Kenneth; Zhang, Donglu; Perrone, Mark; Ferrer, Pam; Giancarli, Mary; Baumann, Jergen; Bird, Eileen; Panchal, Balkrushna; Yang, Yifan; Trippodo, Nick; Barrish, Joel; Macor, John E

Kowala, Mark C; Murugesan, Natesan; Tellew, John; Carlson, Kenneth; Monshizadegan, Hossain; Ryan, Carol; Gu, Zhengxiang; Kane, Bridgette; Fadnis, Leena; Baska, Rose Ann; Beyer, Sophie; Arthur, Susan; Dickinson, Kenneth; Zhang, Donglu; Perrone, Mark; Ferrer, Pam; Giancarli, Mary; Baumann, Jergen; Bird, Eileen; Panchal, Balkrushna; Yang, Yifan; Trippodo, Nick; Barrish, Joel; Macor, John E.

Affiliation

Kowala MC; Department of Metabolic and Cardiovascular Drug Discovery 025-289, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA. mark.kowala@pfizer.com

J Pharmacol Exp Ther ; 309(1): 275-84, 2004 Apr.

Article in En | MEDLINE | ID: mdl-14718594

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Sulfonamides / Biphenyl Compounds / Blood Pressure / Receptor, Angiotensin, Type 1 / Receptor, Endothelin A / Hypertension / Antihypertensive Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: J Pharmacol Exp Ther Year: 2004 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links